FR2353M - New aminoalkyl esters of hydroxy-3beta-pregnene-5-one-20 useful as drugs for epilepsy. - Google Patents

New aminoalkyl esters of hydroxy-3beta-pregnene-5-one-20 useful as drugs for epilepsy.

Info

Publication number
FR2353M
FR2353M FR905983A FR905983A FR2353M FR 2353 M FR2353 M FR 2353M FR 905983 A FR905983 A FR 905983A FR 905983 A FR905983 A FR 905983A FR 2353 M FR2353 M FR 2353M
Authority
FR
France
Prior art keywords
pregnene
3beta
epilepsy
drugs
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR905983A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of FR2353M publication Critical patent/FR2353M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
FR905983A 1961-08-17 1962-08-03 New aminoalkyl esters of hydroxy-3beta-pregnene-5-one-20 useful as drugs for epilepsy. Active FR2353M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13200361A 1961-08-17 1961-08-17

Publications (1)

Publication Number Publication Date
FR2353M true FR2353M (en) 1964-02-24

Family

ID=22451986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR905983A Active FR2353M (en) 1961-08-17 1962-08-03 New aminoalkyl esters of hydroxy-3beta-pregnene-5-one-20 useful as drugs for epilepsy.

Country Status (3)

Country Link
BE (1) BE621470A (en)
FR (1) FR2353M (en)
GB (1) GB966060A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7580187A (en) * 1986-06-23 1988-01-12 Upjohn Company, The Androstane-type and cortical aminoesters
TWI389917B (en) 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Also Published As

Publication number Publication date
BE621470A (en)
GB966060A (en) 1964-08-06

Similar Documents

Publication Publication Date Title
FR1374746A (en) Process for the preparation of ascorbic acid esters, as well as their use
CH409952A (en) Process for the preparation of pseudosapogenin esters
FR2589M (en) Basic esters of 1-benzoxa-cycloalkanecarboxylic acids.
FR2353M (en) New aminoalkyl esters of hydroxy-3beta-pregnene-5-one-20 useful as drugs for epilepsy.
CH375371A (en) Process for the preparation of acyl derivatives of 2-methyl-5-oxy-8- (B-diethylamino-ethoxy) -furo- (2 ', 3': 6.7) -chromone
BE612470A (en) Amyloglucosidase refining process
AT241468B (en) Process for the preparation of new 1,4-bis- {[7'-chloroquinolyl- (4 ')] - aminoalkyl} -piperazines
FR1494701A (en) New ester-amides derived from n-heptanoic acid, and their use as plasticizers
FR93252E (en) Process for the preparation of haloalkyl-thiazols.
FR1299760A (en) Amyloglucosidase refining process
BE608801A (en) Process for the preparation of dithiophosphoric esters.
FR3028M (en) New drugs consisting of basic esters of 3,5-dimethoxy-4-alkoxybenzoic acid.
BE596287A (en) Process for the preparation of O-alkyl-hydroxylamines.
BE587137A (en) Process for the preparation of ortho-disubstituted aromatic amides.
FR1294134A (en) Process for the preparation of alpha-lipoamides
FR1281136A (en) Process for the preparation of manganous acetylacetonate
BE615452A (en) New drugs derived from oxazolidinone-2
BE618999A (en) Process for the preparation of acrylic esters.
BE608424A (en) Process for the preparation of alpha, gamma -disubstituted acetoacetic esters.
BE623148A (en) Process for the preparation of haloalkylthiazols.
BE619299A (en) Preparation of esters from methylacetylene.
FR1435M (en) New drugs derived from 3-methyl-4-pentene-oic acid.
BE599068A (en) Process for the preparation of new esters of the androstane series.
BE597411A (en) Pharmaceutical compositions for the treatment of epilepsy.
FR1596M (en) Drug for the treatment of alcoholism.